Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

By Di Pierro F, et al. Published June 24, 2021 in the International Journal of General Medicine Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential...

read more
Iceland Dumps Moderna COVID-19 Vaccine, While Finland & Norway Join Sweden and Denmark to Halt Use of mRNA-1273 in Young Population

Iceland Dumps Moderna COVID-19 Vaccine, While Finland & Norway Join Sweden and Denmark to Halt Use of mRNA-1273 in Young Population

Trial Site News is skeptical on Covid vaccines so we post selectively from their fact-based reports.  The fact that Scandinavian countries are taking the steps described below underscores the essentially variable meaning of "follow the science" in different countries...

read more
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...

read more